These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 22958293)

  • 41. Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma.
    Davidson B; Skrede M; Silins I; Shih IeM; Trope CG; Flørenes VA
    Cancer; 2007 Sep; 110(6):1264-71. PubMed ID: 17647260
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
    Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
    J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
    Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K
    Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of cell cycle regulators p57(KIP2), cyclin D1, and cyclin E in epithelial ovarian tumors and survival.
    Rosenberg E; Demopoulos RI; Zeleniuch-Jacquotte A; Yee H; Sorich J; Speyer JL; Newcomb EW
    Hum Pathol; 2001 Aug; 32(8):808-13. PubMed ID: 11521224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overexpression of cyclin E isoforms correlates with poor prognosis in rectal cancer.
    Zhou YJ; Xie YT; Gu J; Yan L; Guan GX; Liu X
    Eur J Surg Oncol; 2011 Dec; 37(12):1078-84. PubMed ID: 21944050
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protein expression levels of carcinoembryonic antigen (CEA) in Danish ovarian cancer patients: from the Danish 'MALOVA'ovarian cancer study.
    Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Jarle Christensen I; Gayther S; Jacobs IJ; Høgdall CK
    Pathology; 2008 Aug; 40(5):487-92. PubMed ID: 18604735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene expression profiles as prognostic markers in women with ovarian cancer.
    Jochumsen KM; Tan Q; Høgdall EV; Høgdall C; Kjaer SK; Blaakaer J; Kruse TA; Mogensen O
    Int J Gynecol Cancer; 2009 Oct; 19(7):1205-13. PubMed ID: 19823056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma.
    Mahner S; Baasch C; Schwarz J; Hein S; Wölber L; Jänicke F; Milde-Langosch K
    Br J Cancer; 2008 Oct; 99(8):1269-75. PubMed ID: 18854825
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic factors for survival of epithelial ovarian cancer.
    Linasmita V; Pattaraarchachai J; Daengdeelert P
    Int J Gynaecol Obstet; 2004 Apr; 85(1):66-9. PubMed ID: 15050477
    [No Abstract]   [Full Text] [Related]  

  • 51. Distribution of microsatellite instability in Danish ovarian tumor patients and the prognostic value in ovarian cancer patients.
    Begum FD; Høgdall CK; Kjaer SK; Blaakaer J; Christensen L; Ryan A; Jacobs IJ; Høgdall EV
    Oncol Res; 2008; 17(1):43-9. PubMed ID: 18488714
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of cyclin E expression in patients with ovarian cancer: a Meta-analysis.
    Wang X; Qi X; Ming X; Wang L; Wang Y; Zhao X
    J BUON; 2017; 22(1):64-71. PubMed ID: 28365937
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic significance of deletion and over-expression of the p53 gene in epithelial ovarian cancer.
    Ozalp SS; Yalcin OT; Basaran GN; Artan S; Kabukcuoglu S; Minsin TH
    Eur J Gynaecol Oncol; 2000; 21(3):282-6. PubMed ID: 10949395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low BCL7A expression predicts poor prognosis in ovarian cancer.
    Sun Z; Sun L; He M; Pang Y; Yang Z; Wang J
    J Ovarian Res; 2019 May; 12(1):41. PubMed ID: 31077237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MRI appearances of pure epithelial papillary serous borderline ovarian tumours.
    Naqvi J; Nagaraju E; Ahmad S
    Clin Radiol; 2015 Apr; 70(4):424-32. PubMed ID: 25515794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic impact of chromosome aberrations in ovarian cancer.
    Pejovic T; Himmelmann A; Heim S; Mandahl N; Flodérus UM; Furgyik S; Elmfors B; Helm G; Willén H; Mitelman F
    Br J Cancer; 1992 Feb; 65(2):282-6. PubMed ID: 1739630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel representation of inter-site tumour heterogeneity from pre-treatment computed tomography textures classifies ovarian cancers by clinical outcome.
    Vargas HA; Veeraraghavan H; Micco M; Nougaret S; Lakhman Y; Meier AA; Sosa R; Soslow RA; Levine DA; Weigelt B; Aghajanian C; Hricak H; Deasy J; Snyder A; Sala E
    Eur Radiol; 2017 Sep; 27(9):3991-4001. PubMed ID: 28289945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. c-myc over-expression in human primary ovarian tumours: its relevance to tumour progression.
    Tashiro H; Miyazaki K; Okamura H; Iwai A; Fukumoto M
    Int J Cancer; 1992 Mar; 50(5):828-33. PubMed ID: 1544716
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Accuracy of ovarian cancer ICD-10 diagnosis in a Danish population-based hospital discharge registry.
    Tetsche MS; Nørgaard M; Skriver MV; Andersen ES; Lash TL; Sørensen HT
    Eur J Gynaecol Oncol; 2005; 26(3):266-70. PubMed ID: 15991523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High cyclin E1 protein, but not gene amplification, is prognostic for basal-like breast cancer.
    Aziz D; Lee C; Chin V; Fernandez KJ; Phan Z; ; ; Waring P; Caldon CE
    J Pathol Clin Res; 2022 Jul; 8(4):355-370. PubMed ID: 35384378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.